• Siavash Jabbari, David Andolino, Vivian Weinberg, Brian T Missett, Jason Law, William M Wara, Richard J O'Donnell, Katherine K Matthay, Steven G DuBois, Robert Goldsby, and Daphne A Haas-Kogan.
• Department of Radiation Oncology, University of California, San Francisco, CA, USA.
• Int. J. Radiat. Oncol. Biol. Phys. 2009 Sep 1; 75 (1): 177-82.

PurposeTo evaluate the role of radiation therapy (RT) as a component of multimodality therapy for pediatric desmoids.Methods And MaterialsTwenty-one children diagnosed between 1987 and 2005 were identified. Median age at start of treatment was 13 years (range, 2-21). Primary therapy consisted of resection alone (10), resection + external beam radiation therapy (EBRT) (5), resection + chemotherapy (CT; 3), EBRT alone (1), and CT alone (2).ResultsThe median follow-up from start of treatment is 75.7 months (range, 16-162). Examining patients with gross total resections (GTRs) (-) margins and those who had GTRs (+) margins followed by EBRT, only 2 of 7 failed primary treatment. Conversely, 13 of 14 patients with other primary treatments failed locally. Of the 15 patients who recurred, only 1 patient had a GTR (-) margins. Seven of these patients had salvage therapy that did not include RT, and of these only 2 have no evidence of disease (NED) at last follow-up. In contrast, the remaining 8 patients received RT as a component of their final salvage therapy and 7 of these are NED at last follow-up. At last follow-up, no patient has died, although toxicities of therapy have occurred.ConclusionsLocal control is difficult to achieve in pediatric patients with desmoids. In the setting in which negative surgical margins cannot be achieved, RT plays a key role in achieving NED status. Even after multiple recurrences, successful salvage is achievable, particularly when high-dose focal therapy is incorporated.

23 keywords...

hide…